The Journal of Immunology, Vol 159, Issue 10 4700-4707, Copyright © 1997 by American Association of Immunologists

ARTICLES

Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity

AP Makrigiannis and DW Hoskin
Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.

Rapamycin (RAP) is a potent inhibitor of CTL induction. Since RAP is known to block IL-2 signaling through the IL-2R, we hypothesized that RAP may interfere with CTL generation by inhibiting IL-2-induced expression of granzyme (Gzm) B, perforin, and/or Fas ligand (FasL). MHC- unrestricted mouse CTL induced in vitro with anti-CD3 mAb in the presence of RAP (1 ng/ml) exhibited dramatically reduced cellular proliferation and cytotoxicity against P815 tumor target cells. Gzm B mRNA expression and enzymatic activity in RAP-treated CTL were greatly reduced compared with those in control CTL. Perforin mRNA expression was also reduced by RAP. In contrast, RAP failed to inhibit FasL mRNA expression. RAP, therefore, inhibits induction of the perforin/Gzm B cytolytic pathway but spares Fas/FasL-mediated cytotoxicity. To determine whether RAP exerts a total blockade of the IL-2R signaling pathway, we induced CTL in the presence of both RAP and exogenous rIL-2 (100 U/ml). Under these conditions, Gzm B and perforin mRNA and protein expression as well as cellular proliferation were restored to at least control levels. Surprisingly, inhibition of cytotoxicity was only partially alleviated when CTL were induced in the presence of RAP plus rIL-2, even though CTL conjugated normally with target cells and had an intact granule secretory pathway. We conclude that 1) the inhibitory effect of RAP at the level of the IL-2R is incomplete; and 2) the suppressive effect of RAP on CTL induction is only partly due to inhibition of Gzm B and perforin gene expression.

This article has been cited by other articles:

				R. E. Mills, K. R. Taylor, K. Podshivalova, D. B. McKay, and J. M. Jameson Defects in Skin {gamma}{delta} T Cell Function Contribute to Delayed Wound Repair in Rapamycin-Treated Mice J. Immunol., September 15, 2008; 181(6): 3974 - 3983. [Abstract] [Full Text] [PDF]

				D. Gong and T. R. Malek Cytokine-Dependent Blimp-1 Expression in Activated T Cells Inhibits IL-2 Production J. Immunol., January 1, 2007; 178(1): 242 - 252. [Abstract] [Full Text] [PDF]

				S. M. M. Haeryfar and D. W. Hoskin Thy-1: More than a Mouse Pan-T Cell Marker J. Immunol., September 15, 2004; 173(6): 3581 - 3588. [Abstract] [Full Text] [PDF]

				J. Pardo, M. Buferne, M.-J. Martinez-Lorenzo, J. Naval, A.-M. Schmitt-Verhulst, C. Boyer, and A. Anel Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expression Int. Immunol., December 1, 2003; 15(12): 1441 - 1450. [Abstract] [Full Text] [PDF]

				S. M. M. Haeryfar, M. M. Al-alwan, J. S. Mader, G. Rowden, K. A. West, and D. W. Hoskin Thy-1 Signaling in the Context of Costimulation Provided by Dendritic Cells Provides Signal 1 for T Cell Proliferation and Cytotoxic Effector Molecule Expression, but Fails to Trigger Delivery of the Lethal Hit J. Immunol., July 1, 2003; 171(1): 69 - 77. [Abstract] [Full Text] [PDF]

				J. Zhou and G. G. Meadows Alcohol Consumption Decreases IL-2-Induced NF-{kappa}B Activity in Enriched NK Cells from C57BL/6 Mice Toxicol. Sci., May 1, 2003; 73(1): 72 - 79. [Abstract] [Full Text] [PDF]

				T. Phu, S. M. M. Haeryfar, B. L. Musgrave, and D. W. Hoskin Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro J. Leukoc. Biol., May 1, 2001; 69(5): 803 - 814. [Abstract] [Full Text]

				M. Takahashi, Y. Nakagawa, J. A. Berzofsky, and H. Takahashi Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide Int. Immunol., January 1, 2001; 13(1): 43 - 51. [Abstract] [Full Text] [PDF]

				M. Delgado and D. Ganea Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit T Cell-Mediated Cytotoxicity by Inhibiting Fas Ligand Expression J. Immunol., July 1, 2000; 165(1): 114 - 123. [Abstract] [Full Text] [PDF]

				J. Zhang, I. Scordi, M. J. Smyth, and M. G. Lichtenheld Interleukin 2 Receptor Signaling Regulates the Perforin Gene through Signal Transducer and Activator of Transcription (Stat)5 Activation of Two Enhancers J. Exp. Med., November 1, 1999; 190(9): 1297 - 1308. [Abstract] [Full Text] [PDF]